lumos.png
Lumos Pharma Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
August 02, 2021 08:00 ET | Lumos Pharma, Inc.
AUSTIN, Texas, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, has announced that current...
QMI-Logo-Long-1000px.jpg
Global Delirium Management Market Is Anticipated Grow at a CAGR of 5.6% from 2021 to 2030
August 02, 2021 06:00 ET | Quince Market Insights
Pune, India, Aug. 02, 2021 (GLOBE NEWSWIRE) -- The global delirium management market is expected to value at USD 352.6 million in 2021 and is expected to grow at a CAGR of 5.6% during the forecast...
Paul Mueller Company Logo
Paul Mueller Company Announces Its Second Quarter Earnings of 2021
July 30, 2021 16:07 ET | Paul Mueller Company
SPRINGFIELD, Mo., July 30, 2021 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced earnings for the quarter ended June 30, 2021.    PAUL MUELLER COMPANY SIX-MONTH...
XBiotech logo
XBiotech Announces Payment of Dividend to Holders of Common Stock
July 30, 2021 11:03 ET | XBiotech Inc.
AUSTIN, Texas, July 30, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) (“XBiotech”) has completed payment to holders of its Common Stock of a previously announced dividend in the amount of...
22157.jpg
Two Day Project Management for Pharma Professionals Training Course, September 9th-10th, 2021
July 30, 2021 04:13 ET | Research and Markets
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "Project Management for Pharma Professionals Training Course" conference has been added to ResearchAndMarkets.com's offering. Drug and device...
NEW ATAI-Logo_Primary.png
atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim to develop a more effective nose-to-brain delivery method for atai’s platform of mental health therapeutic programs
July 28, 2021 09:12 ET | atai Life Sciences
BERLIN and BRISBANE, Australia, July 28, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences (“atai” or the “Company”) (Nasdaq: ATAI), a clinical-stage biopharmaceutical company aiming to transform the...
trypf.png
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Developing Evidence-Based Innovation Where Drugs Are Lacking
July 28, 2021 08:30 ET | Tryp Therapeutics Inc.
NEW YORK, July 28, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...
bioxcel-therapeutics-local-250x100.jpg
BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021
July 28, 2021 07:00 ET | BioXcel Therapeutics
NEW HAVEN, Conn., July 28, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (NASDAQ: BTAI), a clinical-stage biopharmaceutical company utilizing artificial...
Green Hygienics Holdings Inc. (GRYN) Appoints David Racz as Senior Vice President of Global Sales and Business Development
July 27, 2021 08:30 ET | Green Hygienics Holdings Inc.
SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company"), announces the appointment of David Racz as Senior...
lumos.png
Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory Board
July 26, 2021 16:18 ET | Lumos Pharma, Inc.
AUSTIN, Texas, July 26, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that Mark Bach,...